Risk Score for Asthma Exacerbation (RSE)

Why Use

A score to help determine likelihood of exacerbation may assist in guiding therapy and/or monitoring.

When to Use

Patients with poorly-controlled asthma.

Formula

Pearls / Pitfalls

The Risk Score for Asthma Exacerbation (RSE) suggests which patients will experience an asthma exacerbation within 6 months. The RSE should be further studied - while its validation was large, it was not validated outside of its own derivation cohort. It was developed from pharmaceutical trials of patients with poorly controlled asthma, so it may not be applicable to patients with milder asthma severity.

Advice

The RSE has been developed from a large cohort and now requires testing through validation studies.

More Information

Score interpretation: RSE Score Likelihood of exacerbation in 6 months 0-10 5% 11-20 5-7% 21-30 7-10% 31-40 10-12% 41-50 12-15% 51-60 15-18% 61-70 18-24% 71-80 24-30% 81-90 30-37% 91-100 37-45% For more information on the Global Initiative for Asthma treatment steps, click here .